Epoetin‐α during radiotherapy for stage III esophageal carcinoma
Dirk Rades(University Hospital Schleswig-Holstein), Volker Rudat(Saad Specialist Hospital), H. Job(Universität Hamburg), Steven E. Schild(Mayo Clinic Hospital), Rudolf Schwarz(Universität Hamburg), Emre F. Yekebas(Universität Hamburg)
Cited by 14
Related Papers
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2019|1k
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023
|Journal of the National Comprehensive Cancer Network|2023|497